MedTrace Logo

Dual Diagnosis (Psychosis and Cannabismisuse): Comparison of Specialized Treatment Versus Unspecified Treatment

NCT00783185 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2010-01-12

No results posted yet for this study

Summary

Intention of the study is to examine, if the symptomatology of dual diagnosis patients is less severe after a special indication training for reduction of cannabis consumption in comparison to unspecified trainings.

Point of interest is psychopathology and consumerism.

Conditions

  • Psychotic Disorders
  • Marijuana Abuse
  • Intervention

Interventions

BEHAVIORAL

Cannabis-Consumption-Reduction-Training

8 sessions within 4 weeks (twice a week, 45 minutes each) Cognitive behavioral therapy with focus on cannabis abuse

BEHAVIORAL

Social competence Training

8 sessions within 4 weeks (twice a week, 45 minutes) training to develop and ameliorate social competences

Sponsors & Collaborators

  • University of Konstanz

    lead OTHER

Principal Investigators

  • Hans Watzl, Dr. · University of Konstanz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2009-06-30
Completion
2010-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00783185 on ClinicalTrials.gov